View in EDS

Harnessing the power of viroimmunotherapy to overcome challenges in cancer therapy.

Saved in:
Bibliographic Details
Title: Harnessing the power of viroimmunotherapy to overcome challenges in cancer therapy.
Authors: LaRocca CJ; Department of Surgery, University of Minnesota, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA., Davydova J; Department of Surgery, University of Minnesota, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Institute of Molecular Virology, University of Minnesota, Minneapolis, MN, USA.
Source: Molecular therapy. Oncology [Mol Ther Oncol] 2024 May 20; Vol. 32 (2), pp. 200811. Date of Electronic Publication: 2024 May 20 (Print Publication: 2024).
Publication Type: News
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918752083706676 Publication Model: eCollection Cited Medium: Print ISSN: 2950-3299 (Print) Linking ISSN: 29503299 NLM ISO Abbreviation: Mol Ther Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38827025
AccessLevel: 2
PubType: Periodical
PubTypeId: serialPeriodical
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Harnessing the power of viroimmunotherapy to overcome challenges in cancer therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22LaRocca+CJ%22">LaRocca CJ</searchLink>; Department of Surgery, University of Minnesota, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Davydova+J%22">Davydova J</searchLink>; Department of Surgery, University of Minnesota, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.; Institute of Molecular Virology, University of Minnesota, Minneapolis, MN, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918752083706676%22">Molecular therapy. Oncology</searchLink> [Mol Ther Oncol] 2024 May 20; Vol. 32 (2), pp. 200811. <i>Date of Electronic Publication: </i>2024 May 20 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: News
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918752083706676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2950-3299 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2229503299%22">29503299 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38827025
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.omton.2024.200811
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 200811
    Titles:
      – TitleFull: Harnessing the power of viroimmunotherapy to overcome challenges in cancer therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: LaRocca CJ
      – PersonEntity:
          Name:
            NameFull: Davydova J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 05
              Text: 2024 May 20
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2950-3299
          Numbering:
            – Type: volume
              Value: 32
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Molecular therapy. Oncology
              Type: main
ResultId 1